CANbridge Pharmaceuticals Enters into Duchenne Muscular Dystrophy Gene Therapy Research Agreement with University of Washington School of Medicine
BEIJING & CAMBRIDGE, Mass.--(BUSINESS WIRE)--CANbridge Pharmaceuticals, Inc., a leading China-based global rare disease-focused biopharmaceutical company committed to the research, development...

UAE and Oman Battle for Standings Edge in ICC World Cup League 2 Push
SBI Research Outlines LTCG Tax Headroom as Air Suvidha Rule Mandated for All Arrivals
Sony kicks off 2026 PlayStation Store Black Friday sale early with up to 75% off games
Democrats Sweep US Midterm Elections, Winning Senate and House as Trump Faces Lame-Duck Presidency
Union Cabinet Approves Two-Year Extension for Agniveer Service Tenure 


















